Privia Health Group's (PRVA) "Market Outperform" Rating Reiterated at JMP Securities

Privia Health Group (NASDAQ:PRVA - Get Free Report)'s stock had its "market outperform" rating reaffirmed by research analysts at JMP Securities in a research note issued on Monday,Benzinga reports. They currently have a $29.00 target price on the stock. JMP Securities' price objective would indicate a potential upside of 26.64% from the stock's current price.

PRVA has been the topic of a number of other reports. Robert W. Baird raised their price target on shares of Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a report on Tuesday, April 15th. Stephens reiterated an "overweight" rating and issued a $26.00 target price on shares of Privia Health Group in a research note on Thursday, January 2nd. Truist Financial lifted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Piper Sandler lifted their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. Finally, Canaccord Genuity Group lifted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $27.14.

Privia Health Group Stock Performance

Privia Health Group stock traded down $0.58 during midday trading on Monday, hitting $22.90. 732,128 shares of the company's stock were exchanged, compared to its average volume of 773,145. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $26.04. The company has a market cap of $2.78 billion, a PE ratio of 229.02, a P/E/G ratio of 3.47 and a beta of 0.88. The firm has a 50-day moving average of $23.55 and a two-hundred day moving average of $22.00.

Insider Activity

In other news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 10.70% of the company's stock.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors have recently made changes to their positions in the company. Riverbridge Partners LLC raised its position in shares of Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock worth $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Loomis Sayles & Co. L P lifted its stake in Privia Health Group by 55.0% in the 4th quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock valued at $27,727,000 after buying an additional 503,002 shares in the last quarter. Durable Capital Partners LP lifted its stake in Privia Health Group by 3.4% in the 4th quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock valued at $224,587,000 after buying an additional 378,255 shares in the last quarter. BlackBarn Capital Partners LP lifted its stake in Privia Health Group by 65.8% in the 4th quarter. BlackBarn Capital Partners LP now owns 663,397 shares of the company's stock valued at $12,969,000 after buying an additional 263,397 shares in the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in Privia Health Group by 19.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock worth $29,110,000 after purchasing an additional 246,393 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.